BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sahin U, Ataca Atilla P, Atilla E, Toprak SK, Demirer T. An overview of hematopoietic stem cell transplantation related thrombotic complications. Critical Reviews in Oncology/Hematology 2016;107:149-55. [DOI: 10.1016/j.critrevonc.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Teti A. Early treatment of osteopetrosis: Paradigm shift to marrow cell transplantation. Bone 2022;:116512. [PMID: 35933094 DOI: 10.1016/j.bone.2022.116512] [Reference Citation Analysis]
2 Palmowski K, Sommerwerck U, Luft T. Pulmonale Manifestation hämatoonkologischer Erkrankungen und Therapien. Seltene Lungenerkrankungen 2022. [DOI: 10.1007/978-3-662-63651-0_37] [Reference Citation Analysis]
3 Basu S, Basu D, Ghara N. Blood Product Support in HSCT. Contemporary Bone Marrow Transplantation 2021. [DOI: 10.1007/978-3-030-36358-1_8] [Reference Citation Analysis]
4 Xu Z, Luo C, Lai P, Ling W, Wu S, Huang X, Huang L, Zhang G, Du X, Weng J. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy. Clin Appl Thromb Hemost 2020;26:1076029619892684. [PMID: 32088973 DOI: 10.1177/1076029619892684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Han Y. [How I treat transplant-associated thrombotic microangiopathy]. Zhonghua Xue Ye Xue Za Zhi 2020;41:272-5. [PMID: 32447928 DOI: 10.3760/cma.j.issn.0253-2727.2020.04.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zhang GC, Zhang YY, Zeng QZ, Meng XY, Zhao P, Fu HX, He Y, Zhu XL, Mo XD, Wang JZ, Yan CH, Wang FR, Chen H, Chen Y, Han W, Wang Y, Xu LP, Liu KY, Huang XJ, Zhang XH. Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation. Thromb Res 2020;194:168-75. [PMID: 32788111 DOI: 10.1016/j.thromres.2020.06.036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Thomas SM, Dietz A, Freyer DR. Considerations for Improving Care and Outcomes of Adolescents and Young Adults Undergoing Hematopoietic Cell Transplantation. Supportive Care Strategies 2020. [DOI: 10.1007/978-3-319-59014-1_11] [Reference Citation Analysis]
8 Basu S, Basu D, Ghara N. Blood Product Support in HSCT. Contemporary Bone Marrow Transplantation 2020. [DOI: 10.1007/978-3-319-64938-2_8-1] [Reference Citation Analysis]
9 Zhang C, Tan X, Yao H, Liu Y, Gao L, Gao L, Kong PY, Zhang X. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report. Transplant Proc 2019;51:3159-62. [PMID: 31711585 DOI: 10.1016/j.transproceed.2019.02.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children. Journal of Pediatric Hematology/Oncology 2019;41:38-41. [DOI: 10.1097/mph.0000000000001263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
11 Cengiz Seval G, Topçuoğlu P, Demirer T. Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation. Balkan Med J 2018;35:131-40. [PMID: 29553463 DOI: 10.4274/balkanmedj.2017.1635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
12 Barrett J. Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%? Best Pract Res Clin Haematol 2018;31:414-9. [PMID: 30466759 DOI: 10.1016/j.beha.2018.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Rudoni J, Jan A, Hosing C, Aung F, Yeh J. Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients. Eur J Haematol 2018;101:389-98. [PMID: 29920784 DOI: 10.1111/ejh.13127] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
14 Jodele S. Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies. Semin Hematol 2018;55:159-66. [PMID: 30032753 DOI: 10.1053/j.seminhematol.2018.04.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
15 Bozdağ SC, Yüksel MK, Demirer T. Adult Stem Cells and Medicine. Advances in Experimental Medicine and Biology 2018. [DOI: 10.1007/5584_2018_184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
16 Wallhult E, Quinn B. Early and Acute Complications and the Principles of HSCT Nursing Care. In: Kenyon M, Babic A, editors. The European Blood and Marrow Transplantation Textbook for Nurses. Cham: Springer International Publishing; 2018. pp. 163-95. [DOI: 10.1007/978-3-319-50026-3_9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Tominaga S, Makino S. Purtscher-like retinopathy and transplant-associated thrombotic microangiopathy. QJM 2017;110:603-4. [PMID: 28575423 DOI: 10.1093/qjmed/hcx107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]